SToP: Venous Thromboembolism Screening in the Trauma Population
| Status: | Recruiting |
|---|---|
| Conditions: | Cardiology, Cardiology, Cardiology, Cardiology, Hospital |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Other |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/1/2018 |
| Start Date: | March 20, 2017 |
| End Date: | June 2020 |
| Contact: | Brent Armbruster |
| Email: | brent.armbruster@imail.org |
| Phone: | 801-507-4605 |
This is a prospective, randomized vanguard trial of trauma patients admitted to the trauma
surgery service at Intermountain Medical Center who are deemed to be at high risk for venous
thromboembolism. Once identified and enrolled, subjects will be randomized to receive
bilateral lower extremity duplex ultrasound surveillance versus no surveillance. The study
will compare the two groups with regard to deep vein thrombosis, pulmonary embolism, and
major and clinically relevant bleeding episode rates, both during the index hospitalization
and at 90 days post-discharge.
surgery service at Intermountain Medical Center who are deemed to be at high risk for venous
thromboembolism. Once identified and enrolled, subjects will be randomized to receive
bilateral lower extremity duplex ultrasound surveillance versus no surveillance. The study
will compare the two groups with regard to deep vein thrombosis, pulmonary embolism, and
major and clinically relevant bleeding episode rates, both during the index hospitalization
and at 90 days post-discharge.
Inclusion Criteria:
1. Inpatient status on Intermountain Medical Center (IMC) trauma surgery service,
admitted within 24 hours of injury.
2. Age ≥18 at the time of injury
3. Meets the definition of high-risk for VTE according to current IMC trauma service
guidelines
Exclusion Criteria:
1. Patient age <18 years at the time of admission to the hospital
2. Pregnancy
3. Prisoners
4. Patients with a life expectancy of less than 30 days
5. Patients with a known hypercoagulable state including:
- Factor V Leiden
- Protein C and S deficiencies
- Dysfibrogenemia of any sort
- Active cancer
- Antiphospholipid antibody syndrome
- History of DVT or PE within past 6 months
- Myeloproliferative disorders
6. Patients on therapeutic anticoagulation who do not have their agent held upon
admission to the hospital.
7. Patient elects to opt-out of the study
We found this trial at
1
site
5121 S Cottonwood St
Murray, Utah 84157
Murray, Utah 84157
(801) 507-7000
Phone: 801-507-4606
Intermountain Medical Center Intermountain Medical Center is one of the most technologically advanced and patient-friendly...
Click here to add this to my saved trials
